73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
AI can be used to detect and grade prostate cancer

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw
NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol use

NELSON trial protocol more sensitive than NLST and may increase the benefits of lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol use
Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar
Blood-clotting protein and blood platelets promote immune evasion, cancer progression

Blood-clotting protein and blood platelets promote immune evasion, cancer progression

byOhio State University Medical CenterCredit: CC0 Public DomainA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard

Blood-clotting protein and blood platelets promote immune evasion, cancer progression

byOhio State University Medical CenterCredit: CC0 Public DomainA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard
Study opens door to targeted treatments for oesophageal cancer

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted
Does eating processed meats cause colorectal cancer?

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December
3-D mammography detected 34% more breast cancers in screening

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum
B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells
Unique gene signature could help predict response to chemotherapy

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations
Structural analysis reveals an unexpected mechanism for a cancer drug

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me